KR102190056B1 - Apparatus and method for providing customized medication information to patednts based on big data - Google Patents

Abstract

This disclosure discloses a method of generating and providing patient-tailored medication information, and in particular, optimal medication for patients by using medication information prescribed by the patient, personal identification information of the patient, current health status information, and surrounding environment information. Information can be provided, and further, medication information with high reliability can be provided by effectively regenerating and providing medication information through periodic question and answer with a patient.

Description

A device for providing customized medication information based on big data and a method for providing medication information {APPARATUS AND METHOD FOR PROVIDING CUSTOMIZED MEDICATION INFORMATION TO PATEDNTS BASED ON BIG DATA}

The present disclosure creates customized medication information using user identification information, surrounding environment information, and current user status information, and provides it to a user device, thereby helping a user to form an accurate and effective medication habit. Disclosed is a provision apparatus and method.

With the current medical division of labor system in place, specialized drugs are being dispensed only by doctor's prescription. However, there is a problem in that a pharmacist cannot always accurately know all information about various prescription drugs, and because individual biometric information and dietary habits are different for each patient, accurate medication information cannot be delivered to a patient.

In addition, in the case of general drugs as well as specialized drugs, information related to drugs is increasing due to the development of science and technology, such as many large pharmaceutical companies constantly developing and marketing new drugs. In addition, as science progresses, the possibility of new drugs that can provide different effects from those before being developed and marketed is gradually increasing, so that the drug-taking guidance information for drugs, which should be known by pharmacists, is bound to increase further.

In spite of the need for accurate medication guidance for various drugs, in the past, medication guidance had to be conducted depending on the knowledge or memory of a pharmacist, and medication guidance such as simply specifying the time and number of medications to take is delivered efficiently to the patient. It was hard to be.

In this case, there is a possibility that incorrect medication instruction may be given due to inaccurate human memory, or the items to be taken medication may be omitted.Therefore, side effects due to medication may occur in patients who have not obtained accurate information about medications that have a large impact on the body. There was a danger.

In addition, from the patient's point of view, even if accurate medication information is heard from a pharmacist, there is a high possibility that the content will be forgotten, and it is difficult to obtain the medication information again when the information written on the medication information is lost.

Therefore, the demand for a technology capable of providing accurate and effective customized medication information by sensing current surrounding environment information along with personal identification information such as patient's personal preference information, current status information, and accumulated medication information has increased. .

Unexamined Patent Publication No. 10-2004-0040842

In one embodiment, after acquiring identification information such as accumulated medication information, user's body information, and health status information of a user, and generating patient-customized medication information using artificial intelligence based on the obtained information, It is intended to provide an apparatus and method for effectively delivering medication information through continuous communication with the device.

According to the first embodiment, a step of acquiring the user's medication history information from an external server may be provided by using the user's identification information.

A step of acquiring drug information prescribed by the user from the drug prescription related document provided by the user may be provided.

A step of acquiring current state information such as the user's body temperature, heart rate, user's blood pressure, and blood glucose information from a user device located close to the user may be provided. According to an embodiment, the user device may mean a user terminal worn by the user or held by the user. Accordingly, the medication information providing apparatus may provide a step of acquiring current state information such as body temperature, heart rate, user's blood pressure, blood sugar information, etc. from a user terminal worn by the user or possessed by the user.

Here, the degree of proximity to the user may vary depending on the performance of at least one sensor included in the user device, and in particular, proximity means that the sensors are located within an area where the user's state can be checked.

According to another embodiment, a user device held by a user may provide the user's state information to a server after receiving the user's state information from another wearable device or another device worn by the user through communication.

Using the first artificial intelligence learning model, based on the user's medication history information, medication information, the user's current status information and surrounding environment information, medication information appropriate to the user's current status, precautions, side effects, and proper intake of medications It is possible to provide a step of generating first user-customized medication information including at least one of the number of times and the appropriate intake time of the medicine.

A step of providing customized medication information to a user device may be provided.

Using the second artificial intelligence learning model, it is possible to provide a step of generating question information related to user-customized medication information and providing the generated question information to a user device.

A step of receiving answer information for question information from a user device may be provided.

A step of modifying the first user-customized medication information based on the answer information and providing the second user-customized medication information according to the state of the user being taken may be provided.

In addition, according to another disclosure, a computer program product including a computer-readable storage medium may be provided.

Using the patient's accumulated medication-related information and current status information, user-customized medication information can be created, and medication information can be modified according to the user's condition by using the question-and-answer information between the patient's device and the physician. It is advantageous for creating customized user medication information.

In addition, by using artificial intelligence data to process and provide precautions such as side effects that may occur with drugs included in the patient's prescription, according to the patient's condition, the patient can obtain medication information suitable for his current condition. have.

By acquiring information such as unknown improvement effects, side effects, and other effects other than prescriptions that may occur from a questionnaire with a patient's device at the start of work, it is possible to easily collect unrecognized effects or side effects of medicines. It can be provided to help in the development of new drugs.

1 is a diagram schematically illustrating an embodiment in which an apparatus for providing medication information according to one disclosure provides medication information to a user device.
2A is a diagram illustrating types of user devices that detect a current state of a user, according to an exemplary embodiment.
FIG. 2B is a diagram illustrating a wearable device that measures a current state of a user and provides state information of the user to a medication information providing device, according to an exemplary embodiment.
FIG. 3 is a diagram for explaining an embodiment in which drug medication information is notified to a user's device according to one start.
4 is a diagram illustrating a device screen for acquiring user information for providing medication information according to an initiation.
FIG. 5 is a diagram illustrating an embodiment in which medication information is regenerated and provided as an answer to a question related to medication information is received from a user device according to one disclosure.
6 is a diagram illustrating a configuration of an apparatus for providing medicine-taking information according to one disclosure.
7 is a block diagram showing a detailed configuration of an apparatus for providing medication information according to an embodiment.
8 is an exemplary diagram of an I-Shape Extended Curvature Gabor Classifier Bunch group.
9 is a flowchart illustrating a method of authenticating a user while maintaining privacy among members by using a block chain according to one disclosure.
10 is a diagram illustrating an example of information stored in a blockchain for user identification and authentication according to an embodiment of the present invention.
11 is a view for explaining the technical features of sharing medication information using a block chain network according to one disclosure.
12 is a diagram for describing an embodiment related to non-contact sensing according to an initiation.

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those of ordinary skill in the art can easily implement the present invention. However, the present invention may be implemented in various forms and is not limited to the embodiments described herein. In the drawings, parts irrelevant to the description are omitted in order to clearly describe the present invention, and similar reference numerals are assigned to similar parts throughout the specification.

Throughout the specification, when a part is said to be "connected" to another part, this includes not only "directly connected" but also "electrically connected" with another element interposed therebetween. . In addition, when a part "includes" a certain component, it means that other components may be further included rather than excluding other components unless specifically stated to the contrary.

Hereinafter, the user refers to a patient who is an insurance subscriber, and the user is a person who claims insurance money by using the medication information providing device, and may be the user himself or a third party such as a family claiming insurance money on behalf of the user. Hereinafter, a description will be made by unifying a patient claiming insurance money and a user of a pharmacy as a user.

Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

1 is a diagram schematically illustrating an embodiment in which an apparatus for providing medication information according to one disclosure provides medication information to a user device.

The medication information providing device 200 is preferably a management server, but is not limited thereto, and may be a medication information providing terminal in the form of a kiosk arranged in a pharmacy or hospital. When a chip capable of machine learning is used in the terminal, the method of the present invention can also be implemented in the terminal providing the medication information.

According to one disclosure, the medication information providing device 200 may be any one of a kiosk, a server, a portable device, and a computer device, and is not limited in its form. In addition, although FIG. 1 illustrates a process of receiving a plurality of pieces of information, generating medication information, and transmitting it to a user device, using a plurality of devices, this is only an exemplary embodiment and is not limited thereto.

For example, the medication information providing device 200 includes a mobile phone, a smart phone, a laptop computer, a tablet PC, an e-book terminal, a digital broadcasting terminal, personal digital assistants (PDA), and portable multimedia (PMP). Player), navigation, MP3 player, digital camera, glasses, wrist watch, etc., can be implemented.In this case, the user's biometric information is received in real time and medication information through artificial intelligence learning. Can be created.

According to another embodiment, when the medication information providing apparatus 200 is implemented as a server, the server may be located close to a user or remotely. At this time, the medication information providing device 200 may receive information by sensing a user's bio-signal from a device located close to the user, or receive information on the surrounding environment, and the user at a kiosk, a health-related website, or other hospital server. It is possible to generate medication information by receiving information on the treatment history of the patient and learning the received information through artificial intelligence learning. By the start of the day, the medication information providing device 200 may generate medication information and transmit it to a kiosk, a user device, an external device, a hospital server, a server of a public institution, etc., at this time, with external devices through a local/far network Communication can be made through a communication connection or a connection through a blockchain, and the communication method is not limited.

As described above, it is obvious that the process of generating the medication information described in the present invention is not limited by the physical device. In addition, the method of generating medication information herein may be implemented in the form of program instructions that can be executed through various computer means and recorded in a computer-readable medium. The computer-readable medium may include program instructions, data files, data structures, and the like alone or in combination. The program instructions recorded in the medium may be specially designed and configured for the present invention, or may be known and usable to those skilled in computer software. Examples of computer-readable recording media include magnetic media such as hard disks, floppy disks, and magnetic tapes, optical media such as CD-ROMs and DVDs, and magnetic media such as floptical disks. -A hardware device specially configured to store and execute program instructions such as magneto-optical media, and ROM, RAM, flash memory, and the like. Examples of the program instructions include not only machine language codes such as those produced by a compiler, but also high-level language codes that can be executed by a computer using an interpreter or the like.

According to one disclosure, the apparatus for providing medication information may provide a step of acquiring the user's medication history information from the server by using the user's identification information.

According to one disclosure, the apparatus for providing medication information may provide a step of acquiring medication information prescribed by the user from a medication prescription related document provided by the user.

According to one disclosure, the apparatus for providing medication information may provide a step of acquiring current state information, such as body temperature, heart rate, user's blood pressure, and blood sugar information, from a user device located close to the user.

According to the start of the day, the medication information providing device uses the first artificial intelligence learning model, based on the user's medication history information, medication information, the user's current status information, and surrounding environment information, medication information suitable for the user's current status. , Precautions, side effects, the appropriate number of times of ingestion of the drug, and the step of generating the first user-customized medication information including the proper intake time of the drug may be provided.

According to one disclosure, the device for providing medication information may provide a step of providing customized medication information to the user device.

According to one disclosure, the apparatus for providing medication information may provide a step of generating question information related to user-customized medication information and providing the generated question information to a user device by using an artificial intelligence second learning model.

According to one disclosure, the apparatus for providing medication information may provide a step of receiving answer information for question information from a user device.

According to one disclosure, the apparatus for providing medication information may provide a step of modifying the first user-customized medication information based on the answer information and providing the second user-customized medication information according to the state of the user who is taking the medication. Therefore, there is an advantage of being able to provide customized medication information in real time.

According to one disclosure, the apparatus for providing medication information may provide a step of acquiring surrounding environment information including temperature, humidity, fine dust concentration, and weather information around a location where the user is currently located from the user device or server.

According to one disclosure, the apparatus for providing medication information may provide a step of modifying the first user-customized medication information so that the effect of the user's ingestion of the medication is maximized based on the surrounding environment information.

According to one disclosure, the device for providing medication information may provide a step of providing the modified first user-customized medication information to the user device.

By the start of the day, the medication information providing device is based on the drug identification information, disease name information, diagnosis name information, medical history information, medical treatment history information, information on the prescribed drug, and physical characteristics of the user related to the drug information prescribed by the user. Based on the result of learning the drug medication information generated based on medical treatment information, an artificial intelligence first learning model can be obtained, and the acquired artificial intelligence first learning model can be used to generate drug medication information to be provided to the user. have.

At this time, the first learning model is information about the user's current state. By setting a weight to at least one of the user's genetic characteristic information and the surrounding environment information, it may be characterized in that the time-based medication medication information according to the user's current state information is generated.

For example, the first learning model may set a weight on at least one of information on a user's current state, information on a user's genetic characteristics, and information on a surrounding environment according to a user's request. For example, when receiving a request to generate new drug medication information along with information that the user's current blood pressure has risen from the user device, the first learning model weights the blood pressure increase information among the user's current state information. New drug medication information can be created. At this time, the first learning model is an artificial intelligence learning model, taking into account the patient's status information, risk information due to blood pressure rise, blood pressure rise factor according to environmental information, environmental information based on genetic factors, etc., and taking medicines based on big data. Can generate information.

According to one disclosure, the first learning model may generate drug medication information by setting weights differently according to each information. For example, the first learning model may generate drug medication information by focusing on the user's current state information by assigning a weight of 0.7 to the current state information of the user and applying a weight of 0.3 to the surrounding environment information. In this case, whether to apply the weight to which information and how much weight to apply the weight to how many pieces of information may be automatically set based on a user's selection or by artificial intelligence.

By initiation, the medication information providing device obtains health status information including at least one of the user's psychological status, drinking status, pain status, meal information, allergy information, family history information, and sleep status information from the user device. Steps can be provided.

According to one disclosure, the device for providing medication information may perform the step of generating question information related to user-customized medication information by using the second artificial intelligence learning model in which medication information suitable for each situation is learned using health status information. Can provide.

For example, if there is hair loss in the user's family history, question information about whether the hair loss effect occurs, whether it is improved, or whether it is newly occurring may be generated according to the medication effect.

According to one disclosure, the apparatus for providing medication information may provide a step of regenerating user-customized medication information based on response information periodically acquired from the user device.

For example, in the case of answering that hair loss has occurred, information including information on whether to reduce or stop the drug being taken may be generated and provided.

According to one disclosure, the apparatus for providing medication information may provide a step of encrypting the first user-customized medication information and the second user-customized medication information using a block chain.

According to one disclosure, the device for providing medication information may provide a step of storing the encrypted first user-customized medication information and the second user-customized medication information to be provided to at least one device authenticated through a block chain.

According to one disclosure, the at least one device may include a hospital server, a pharmaceutical company server, a drug supply company, and the like, but is not limited thereto.

For better understanding, refer to FIG. 10.

10 is a diagram illustrating an example of information stored in a blockchain for user identification and authentication according to an embodiment of the present invention.

Referring to FIG. 10, the medication information providing device stores and manages at least one of personal information consent, authentication code, and access token in the blockchain in order to authenticate at least one user device according to a standard protocol such as Oauth. .

The medication information providing device stores the pair of authentication information (eg, user ID) and data in the IN area and OUT area of the block 200 of the block chain. The medication information providing device generates authentication information in various forms so that information such as a user authentication code and an access code required for access to a pharmaceutical company, a hospital, etc. can be easily stored, managed, and searched.

First, the medication information providing apparatus generates first authentication information based on user identification information. The apparatus for providing medication information may generate a hash value calculated by using user identification information as an input of a hash function as first authentication information. The medication information providing device stores the first authentication information in the IN area of the block, and stores drug prescription information, user identification information, and consent of personal information in the OUT area of the same block.

According to one disclosure, the user identification information may include the user's biometric information, and may include, for example, the user's fingerprint, voice, face recognition, iris recognition, and the like, and there is no restriction on the biometric information.

By initiation, the parameter values (temperature, humidity, fine dust, etc.) applied to artificial intelligence learning and prediction can be stored in the blockchain network.

The medication information providing device generates second authentication information based on the first random number value. The device for providing the medication information may generate the first random number value as second authentication information as it is, or may generate a hash value for the first random number value as second authentication information. The second authentication information is used as an authentication code issued to an authentication application in the process of authentication through the blockchain. The medication information providing device stores the second authentication information in the IN area of the block, and stores drug prescription information and user identification information in the OUT area of the same block. Therefore, the device for providing medication information can easily check whether the authentication code is issued to a customer who has been treated at a hospital or a pharmacy that has been issued to a customer who has been prescribed medication by searching the block chain using the authentication code as a kit value.

The medication information providing apparatus generates third authentication information based on the second random number value. The apparatus for providing the medication information may generate the second random number value as third authentication information or may generate a hash value for the second random number value as third authentication information. The third authentication information is used as an access token in the process of authentication. The medication information providing apparatus stores third authentication information in the IN area of the block, and stores drug prescription information and user identification information in the OUT area of the same block. Therefore, like the authentication code, the device for providing medication information can easily check whether the access token for the customer of a specific company has been issued effectively by searching the blockchain using the access token as a kit value.

The medication information providing device also generates fourth authentication information based on drug prescription information and user identification information. The medication information providing apparatus may generate a hash value calculated by using the drug prescription information and user identification information as inputs of the hash function as the fourth authentication information. The medication information providing apparatus stores the fourth authentication information in the IN area of the block, and stores the third authentication information, that is, the access token, in the OUT area of the same block. Therefore, the device for providing medication information can easily check the access token issued to the customer by searching the blockchain based on the information of a specific customer of a specific affiliate.

In addition, the medication information providing device may generate the fifth authentication information based on the affiliate identification information using the blockchain and store it in a block of the blockchain together with the affiliate identification information.

The authentication code or access token may have a validity period. The device for providing the medication information may determine whether the authentication code or the access token has a preset validity period based on the generation time of the block in which the authentication code or the access token is stored. When receiving an authentication code or an access token whose validity period has elapsed from a user device or the like, the medication-taking information providing device may inform that the authentication code or access token is not valid and to perform the login authentication process again.

By the beginning, the medication information providing device generates first authentication information based on user identification information for automatic authentication of at least one device, includes the first authentication information in the IN area of the transaction, and Blocks containing prescription information, user identification information, and consent of personal information in the OUT area of the transaction can be stored in the blockchain.

In addition, by the start of the day, the medication information providing device generates second authentication information based on the first random number value, includes the second authentication information in the IN area of the transaction, and stores drug prescription information and user identification information. Blocks included in the OUT area of the transaction can be stored in the blockchain, and second authentication information can be issued as an authentication code.

In addition, by the start of the day, the medication information providing device generates third authentication information based on the second random number value, includes the third authentication information in the IN area of the transaction, and stores drug prescription information and user identification information. Blocks included in the OUT area of the transaction can be stored in the blockchain, and third authentication information can be issued as an access token.

In addition, by the start of the day, the medication information providing device searches the blockchain based on the user identification information included in the patient-customized medication information request requested from at least one device, and corresponds to the first authentication information and the third authentication information. The personal information consent and the access token are checked, and if the personal information consent and the access token exist, patient-customized medication information may be provided to at least one device. As seen above, the step of acquiring drug information prescribed by the user includes reading an image of at least one of the user's medical certificate, medical card, prescription, and insurance certificate, and reading the OCR (optical character reader) from the read OCR information. It may be characterized by acquiring at least one of insurance contract information, personal characteristic information, prescribed drug information, medication information, and treatment information.

In addition, it is possible to provide a computer program product including a computer-readable storage medium including instructions for performing the methods provided by the present invention.

2A is a diagram illustrating types of user devices that detect a current state of a user, according to an exemplary embodiment.

According to an embodiment, a user may include a plurality of user devices 100. According to an embodiment, a user may additionally include a plurality of wearable devices 100-1, 100-2, 100-3, 100-4, and 100-5 capable of measuring biometric information. The user device 100 may also be one of the types of wearable devices. The user device 100 may register a plurality of wearable devices 100-1, 100-2, 100-3, 100-4, and 100-5.

The user device 100 may directly measure the user's biometric information. Also, the user device 100 may obtain information on the current state of the user from the plurality of wearable devices 100-1, 100-2, 100-3, 100-4 and 100-5.

The user device 100 may detect the current state of the user and provide it to the medication information providing device.

FIG. 2B is a diagram illustrating a wearable device that measures a current state of a user and provides state information of the user to a medication information providing device, according to an exemplary embodiment.

As shown in FIG. 2B, the wearable device 100 may include a probe 180. The probe 180 may be attached to the user's body. According to an embodiment, the probe 180 may be attached to the user's body in a non-contact manner. According to an embodiment, the probe 180 may be mounted in an inner skin of leather, rubber, or plastic included in the wearable device 100.

The probe 180 may be installed to obtain impedance data from a portion attached to the user's body. The probe 180 may be installed to measure a change in blood sugar concentration resulting in a change in the impedance spectrum of the dielectric in the blood.

According to an embodiment, the probe 180 may measure an impedance change using an AC current. The probe 180 may detect a change in impedance of a user's body by radiating an AC current and detecting a change in the returned current.

By initiation, the user device 100 may determine whether the user drank a lot of alcohol the previous day by analyzing the change in blood alcohol concentration by detecting a change in the user's body impedance, or determine whether the user's blood oxygen concentration By analyzing, it is possible to determine the user's fatigue and sleep conditions.

FIG. 3 is a diagram for explaining an embodiment in which drug medication information is notified to a user's device according to one start.

According to one disclosure, when the user's device is a wearable watch, simple information on medication medication may be notified on the wearable device.

For example, a notification message 2002 may be displayed on the wearable watch 100. In the notification message 2002, the current time is the drug taking time, and in particular, it may include information that one pill should be taken 30 minutes after a meal. In addition, the notification message 2002 may include a notice. For example, the notification message 2002 may include a content to eat at the same time as a vitamin in order to maximize the effect of a medicine to be eaten at present.

4 is a diagram illustrating a device screen for acquiring user information for providing medication information according to an initiation.

According to the start of the day, the screen of the device providing medication information may include current prescription details, customer identification information, billed amount, customer specific details, past prescription details, customer notepad, past prescription dispensing list, and the like. However, it is obvious that the items displayed on the screen are exemplified and may vary according to the results of artificial intelligence search.

FIG. 5 is a diagram illustrating an embodiment in which medication information is regenerated and provided as an answer to a question related to medication information is received from a user device according to one disclosure.

By initiation, the medication information providing apparatus may provide a step of providing notification information according to a time when a user should take a medication. For example, the medication information providing device may provide a notification about the intake of the medication once every 8 hours if the medication is a medication that must be taken three times a day and once every 8 hours.

By the start of the day, the medication information providing device may provide a step of transmitting question information to the user device after a certain period of time for the user to take the medication has elapsed.

For example, the medication information providing device is a user device, whether or not the user has taken the medication, how many times a day has taken the medication, whether the medication has been taken according to accurate medication information, and whether there are any abnormalities after taking the medication, You can ask questions about whether or not there is an improvement after taking the medication.

According to one disclosure, the apparatus for providing medication information may provide a step of providing a warning notification to the user device when the response information to the question information is not received from the user device.

For example, when the user device does not receive a response to the question "Did you take the second medicine of the day?" have. In this case, the warning notification may include at least one of a visual message, an audible notification, and a vibration notification.

According to one disclosure, the apparatus for providing medication information may provide a step of detecting new effect information or new side effect information not included in the medication medication information based on the response information.

For example, the device for providing medication information may ask whether side effects such as hair loss have occurred after taking the medication, based on the user's family history. At this time, when a response that hair loss has occurred from the user device is received, it can be determined that the drug may affect hair loss.

Alternatively, when the medication information providing device receives a response from the user device indicating that hair loss is improved, it may be determined that a new effect of improving hair loss has occurred, even if the drug was not a drug related to hair loss.

According to one disclosure, the apparatus for providing medication information may provide a step of generating additional medication information by matching current state information of the user with new effect information or new side effect information.

For example, if a positive effect of hair loss improvement occurs after a user takes a medicine prescribed for headache, the user, the prescribed medicine, the current state of the user, the surrounding environment, etc. Can generate information. In this case, the additional medication information may include a user's characteristics and a new effect corresponding to the previously prescribed medication information. The new medication information may be stored in a database or a cloud server.

According to one disclosure, the device for providing medication information may provide a step of transmitting the additional medication information to a server for a pharmaceutical company manufacturing a pharmaceutical product. For example, the company server may include, but is not limited to, a hospital server, a server of a medical institution, a server of a drug provider, and a pharmaceutical company. According to one disclosure, when receiving a continuous request for additional medication information from a pharmaceutical company server, the apparatus for providing medication information may provide a step of requesting additional question information related to the additional medication information to the pharmaceutical company server.

For example, a server of a drug manufacturing company that manufactures headache drugs can notify a user who took a specific drug that the effect of improving hair loss has occurred. Drug manufacturing companies can use these effects to start developing new drugs, so they may need more information. Accordingly, the pharmaceutical manufacturing company may create various questions about the new effects of the existing drugs and transmit them to the medication information providing device. In this case, the medication information providing apparatus may receive a certain fee in exchange for providing a new effect/side effect or in return for receiving a new question, and may provide some of the certain fee to the user.

As the additional question information is received from the pharmaceutical company server, the step of transmitting the additional question information to the user device may be provided.

As the additional response information is received from the user device, a step of generating new additional medication information based on the additional response information may be provided. According to one disclosure, the apparatus for providing medication information may provide a step of receiving a payment based on cryptocurrency from the pharmaceutical company server by providing additional medication information to the pharmaceutical company server.

In addition, according to one disclosure, the device for providing the medication information may provide a step of providing a fee based on cryptocurrency to an account of the user device as additional response information is received from the user device.

At this time, the medication information providing device has the advantage of being able to quickly provide new medication information, etc., preferentially to a company server or user device connected to a previously signed blockchain. In addition, since the provision and receipt of such information is performed within a blockchain where privacy is maintained, the effect of secrecy can be strengthened.

By way of disclosure, in order to supplement the above contents, FIG. 9 will be described first.

9 is a flow chart illustrating a method of authenticating a user while maintaining privacy between members using a block chain according to one disclosure.

By the beginning, in order to authenticate the user, the medication information providing device 200 is a FIDO (Fast Identity Online) server 500, an authentication application server 510, an authentication service linkage server 520, a blockchain server 530 ), and the main server 540. According to an embodiment, the configuration of the medication information providing apparatus 200 may be modified in various forms.

According to one disclosure, as a method for obtaining information necessary for the medication information providing device 200 to generate medication-related information from a user terminal or an external device, the use of an insurance application will be described as an example, and a method for this Do not limit. The medication information providing apparatus 200 may execute a program for generating medication information using a predetermined application, and does not limit the type of application. Further, an extended example of authenticating a user and transmitting the acquired information to another company server (eg, an insurance company server, a pharmaceutical company server, etc.) will be described.

When the user drives the insurance application 104, the login screen 600 is displayed on the medication information providing device 200. On one side of the login screen, there is a button that can log in to the account of the authentication application 102 as an agent. When the user clicks the button, the insurance application 104 transmits a login request to the authentication application 102 (S500).

The authentication application 102 performs authentication through the FIDO server 500 (S502, S504). For example, the authentication application 102 displays a fingerprint authentication request screen on the user device, receives the user's fingerprint, and transmits it to the FIDO server 500, and the FIDO server 500 succeeds in authentication if the fingerprint is a registered fingerprint. The result (eg, FIDO token) is notified to the authentication application 102. The present embodiment illustrates fingerprint authentication through the FIDO server 500 as a user authentication method, but is not limited thereto, and various conventional user authentication methods may be applied.

According to one disclosure, the authentication application 102 may extract facial feature points from an image photographed of the user's face, and perform user authentication using the facial feature points. The authentication application 102 transmits the feature point of the user's face to the FIDO server 500, and the FIDO server 500 determines whether the feature point of the user's face coincides with the feature point of the previously registered user's face, thereby authenticating The result of success (eg, FIDO token) can be notified to the authentication application 102. If user authentication is successful, the authentication application 102 requests an authentication code from the authentication application server 510 (S506). The authentication code request may include an authentication success result (FIDO token) received from the FIDO server 500. The authentication application server 510 verifies the FIDO token included in the authentication code request through the FIDO server 500 when requesting the authentication code of the authentication application 102 (S508), and if the verification is successful, the authentication application 102 The authentication code request of is transmitted to the authentication service interlocking server 520 (S510).

The interworking server 520 checks whether the personal information is consented to the blockchain server 530 based on the identification information of the medication information providing device and the user identification information (S512). The identification information and the user identification information of the medication information providing device may be stored in advance in the insurance application and the authentication application, or may be input by the user through the user device.

The blockchain server 530 searches the blockchain with the kit value generated based on the identification information of the medication information providing device and the user identification information, and checks whether there is a user's consent to provide personal information to the corresponding medication information providing device.

For example, since the consent of personal information is stored in the blockchain together with the first authentication identification information, the blockchain server 530 uses the kit value generated based on the identification information of the medication information providing device 200 and the user identification information. By searching the IN area of each block of the blockchain, it is possible to determine whether there is consent to personal information.

The blockchain server 530 generates an authentication code and transmits it to the authentication service linking server 520 (S514), and the authentication service linking server 520 determines whether the received authentication code and personal information consent to the authentication application 102 Forward (S516). If there is no consent to provide personal information to the insurance application 104, the medication information providing device 200 displays a screen for consent to provide personal information, receives personal information consent from the user, and receives it from the interlocking server 520 ) To the blockchain server 530 (S518, S520). When the block chain server 530 receives personal information consent, it stores it in a block of the block chain together with the first authentication identification information.

The authentication application 102, when the personal information consent exists and receives the authentication code from the blockchain server 530, transmits the authentication code to the insurance application 104 (S522). The insurance application 104 requests an access token for accessing the insurance company server based on the authentication code (S524). The access token request is transmitted to the blockchain server 530 via the interworking server 520 (S526).

The blockchain server 530 generates third authentication identification information and issues it as an access token (S528). The access token is transmitted to the insurance application 104 via the interworking server 520 (S530). When issuance of the normal access token is completed, a login success message may be displayed on the user device. After issuing an access token, the insurance application 104 may access various services such as inquiry of desired information by accessing the insurance company server using it.

According to an embodiment, if the insurance application 104 installed in the medication information providing device 200 accesses the insurance company server for the first time, the insurance company server determines whether or not to agree to the pharmacy membership agreement, the medication information providing device 200 or the user device. You can ask at (100). By way of disclosure, although the insurance company server is not shown on the drawing, it is apparent that the user device and the insurance company server can communicate through a network.

In addition, the medication information providing apparatus 200 may migrate data related to the user's medication guidance to the insurance company server.

In another embodiment, the insurance application 104 may request and receive personal information of the user. That is, the user transmits a request for personal information through the insurance application 104 (S532). The personal information request includes an access token issued by the insurance application 104.

The interworking server 520 verifies whether the access token included in the personal information request through the block chain server 530 has been normally issued, and whether there is a personal information consent for the user who uses the corresponding medication information providing device 200. Verify (S534). If the verification is successful, the interworking server 520 requests and receives the personal information of the user stored in the backbone server 540 or the medication information providing device 200 (S536, S538), and transmits it to the insurance application 104. (S540). The personal information inquiry process (S532, S534, S536, and S538) of this embodiment may be omitted depending on the embodiment.

According to one disclosure, the device 200 for providing medication information may generate and provide accurate medication information using user identification information obtained by authenticating a user.

6 is a diagram illustrating a configuration of an apparatus for providing medicine-taking information according to one disclosure.

By an initiation, a medication information providing device 200 including a memory storing instructions executable by the processor 1300 and the processor 1300 is provided, and the processor 1300 by the initiation is performed by executing the instructions. , User identification information and medical identification information are extracted from insurance claim proof information, corresponding insurance claim information is generated from user identification information and medical identification information, and the content requesting payment of a fee corresponding to the insurance claim information is displayed on the screen. And, in response to a response of obtaining a fee through the medication information providing device, the insurance claim information is transmitted to the insurance company server, the user's interest is obtained based on the user identification information, and a plurality of advertisements previously stored according to the user's interest A content priority may be generated, a plurality of advertisement content may be sequentially exposed according to the priority, and a receipt may be output through the display unit upon completion of the step of transmitting the insurance claim information.

By initiation, the processor 1300 checks the number of claims for insurance claims obtained every predetermined period, and when the number of claims for insurance claims does not exceed a predetermined threshold, at least one other medication information providing device through the blockchain network Execute a sync mode that synchronizes the consensus method with 200 in real time, and when the number of insurance claims exceeds a predetermined threshold, the consensus method with the terminal 200 is executed in real time. By executing an un-sync mode, it is possible to deactivate data synchronization with at least one other medication information providing device 200.

By the start, the processor 1300 automatically authenticates the user identification information using a blockchain in order to synchronize real-time data with at least one other medication information providing device 200 in the sync mode, and the processor 1300 ), for automatic authentication of user identification information, generates first authentication information based on identification information and user identification information of the medication information providing device, and includes the first authentication information in the IN area of the transaction, and medication information A block including identification information of the providing device, user identification information, and personal information consent in the transaction OUT area is stored in the blockchain, and second authentication information is generated based on the first random number, and the second A block containing authentication information in the IN area of the transaction, identification information of the medication information providing device and user identification information in the OUT area of the transaction is stored in the blockchain, and the second authentication information is an authentication code. Is issued, generates third authentication information based on the second random number, includes the third authentication information in the IN area of the transaction, and includes identification information of the medication information providing device and user identification information of the transaction. The block included in the OUT) area is stored in the blockchain, third authentication information is issued as an access token, and identification information and user identification information of the medication information providing device included in the personal information request of the insurance application of the user's device are stored. Based on the blockchain search, personal information consent and access tokens corresponding to the first authentication information and the third authentication information are checked, and if personal information consent and access tokens exist, personal information can be provided with insurance.

In addition, by the start, the processor 1300, in order to issue the third authentication information as an access token, based on the identification information and the user identification information of the medication information providing device included in the authentication code request of the insurance application of the user device. The blockchain can be searched with to check whether the personal information corresponding to the first authentication information is consented, and if there is consent to the personal information, the second authentication information can be transmitted to the insurance application.

By the start of the day, the medication information providing device 200 operates based on the first blockchain using the first cryptocurrency, and provides second medication information operating based on the second blockchain using the second cryptocurrency. Can communicate with device 200.

By the start of the day, the processor 1300 in the sync mode, the user's first insurance claim information, the second medication information providing device 200, the user's second insurance claim information, the first insurance claim information to claim a second insurance claim Acquires the first transaction information requesting the summation of information, the second transaction information requesting the summation of the first insurance claim information to the second insurance claim information, and the first transaction information is the medication information providing device 200 and the insurance company server If the terms of the agreement between the two are satisfied, it is dependent on the validity of the second transaction information to add the second claim information to the first claim information, and to prove the terms of the agreement to the first claim information to which the second claim information is added. Digital signatures can be added and transmitted to nodes on the network of the first blockchain.

By the start, the processor 1300 calculates a first hash value by applying a hash function to the first insurance claim information to which the second claim information is added, and the user's identification information and medication information providing device 200 By encrypting the first hash value using the identification information of and the identification information of the second medication information providing device 200, a first password representing the digital signature of the first transaction information is generated, and the second insurance claim information is added The generated first password and first insurance claim information may be transmitted to a node on the network of the first blockchain.

In addition, the receiving of user identification information from the user may include recognizing the user's face and receiving the user's facial identification information, receiving the user's fingerprint information, receiving the user's ID/PW information, and It may include at least one of the step of receiving the insurance claim proof information.

By the beginning, the user's insurance claim proof information is included in an electronic code attached to at least one of a medical certificate, a medical card and a prescription, and an electronic code attached to the insurance certificate, and the electronic code is a barcode, a QR code, an NFC tag, and an image. It may include at least one of the tags.

By the start, the processor 1300 uses the user's identification information obtained from the user's insurance claim proof information, the user's family history, the user's insurance subscription information, the user's family's insurance subscription information, and the user's insurance amount. Is obtained, it is possible to determine whether or not the user's medical diagnosis contents can be guaranteed by the user's insurance, and control to display whether the user's medical diagnosis contents are covered by the insurance.

By initiation, the processor 1300 receives a user input for selecting an advertisement service provided to the user, transmits information related to the selected advertisement service to the user's device, and provides a service related to the advertisement service. The user's identification information can be transmitted.

At the beginning, the processor 1300 acquires a second learning model based on the result of learning the user's interest related to insurance payment information and medication information using a recurrent neural network (RNN) that is an artificial intelligence learning model. And, using the second learning model, it is possible to determine an advertisement phrase to be provided to the user.

7 is a block diagram showing a detailed configuration of an apparatus for providing medication information according to an embodiment.

As shown in FIG. 7, the apparatus 200 for providing medication information according to an embodiment may include a control unit 1300, a communication unit 1500, and a memory 1700. However, not all of the constituent elements shown in FIG. 7 are essential constituents of the medication information providing apparatus 200. The medication information providing device 200 may be implemented by more components than those shown in FIG. 7, or the medication information providing device 200 may be implemented by fewer components than the components shown in FIG. 7. have.

For example, as shown in FIG. 7, the apparatus 200 for providing medication information according to an embodiment includes a user input unit 1100, an output unit in addition to the control unit 1300, the communication unit 1500, and the memory 1700. It may further include 1200, a sensing unit 1400, and an A/V input unit 1600.

For example, the medication information providing device 200 according to an embodiment may be a board for a medication information providing device for the control unit 1300, the communication unit 1500, and the memory 1700, and medication information according to an embodiment In addition to the control unit 1300, the communication unit 1500, and the memory 1700, the providing device 200 includes at least one of the user input unit 1100, the output unit 1200, the sensing unit 1400, and the A/V input unit 1600. It may be a medication information providing device including one more.

The user input unit 1100 refers to a means for a user to input data for controlling the medication information providing apparatus 200. For example, the user input unit 1100 includes a key pad, a dome switch, a touch pad (contact type capacitance method, pressure type resistive film method, infrared detection method, surface ultrasonic conduction method, integral type). Tension measurement method, piezo effect method, etc.), a jog wheel, a jog switch, and the like, but are not limited thereto.

The user input unit 1100 may receive a user input for controlling an operation of a module installed in the medication information providing device.

The output unit 1200 may output an audio signal, a video signal, or a vibration signal, and the output unit 1200 may include a display unit 1210, an audio output unit 1220, and a vibration motor 1230. have. In an embodiment, the output unit 1200 may output a notification message in the form of audio, video, and/or vibration.

The display 1210 displays and outputs information processed by the medication information providing apparatus 200.

The sound output unit 1220 outputs audio data received from the communication unit 1500 or stored in the memory 1700. In addition, the sound output unit 1220 outputs sound signals related to functions (eg, a call signal reception sound, a message reception sound, and a notification sound) performed by the medication information providing apparatus 200. For example, the sound output unit 1220 may output an alarm sound for notifying that an event has occurred.

The controller 1300 generally controls the overall operation of the medication information providing apparatus 200. For example, by executing programs stored in the memory 1700, the control unit 1300, the user input unit 1100, the output unit 1200, the sensing unit 1400, the communication unit 1500, the A/V input unit 1600 ) And so on. In addition, the controller 1300 may perform a function of the medication information providing apparatus 200 by executing programs stored in the memory 1700. The control unit 1300 may include at least one processor. The controller 1300 may include a plurality of processors or may include one integrated processor according to its function and role. In an embodiment, the controller 1300 may include at least one processor that provides a notification message by executing at least one program stored in the memory 1700.

The sensing unit 1400 may detect a state of the medication information providing device 200, a user's state, or a state around the medication information providing device 200, and transmit the detected information to the control unit 1300.

The sensing unit 1400 includes a magnetic sensor 1410, an acceleration sensor 1420, a temperature/humidity sensor 1430, an infrared sensor 1440, a gyroscope sensor 1450, and a position sensor. (For example, a GPS) 1460, an atmospheric pressure sensor 1470, a proximity sensor 1480, and an RGB sensor 1490 may be included, but the present invention is not limited thereto. Since the function of each sensor can be intuitively inferred by a person skilled in the art from its name, a detailed description will be omitted.

The communication unit 1500 may include one or more components that allow the medication information providing device 200 to communicate with other medication information providing devices (not shown) and the server 2000. For example, the communication unit 1500 may include a short range communication unit 1510, a mobile communication unit 1520, and a broadcast reception unit 1530. Another device for providing medication information (not shown) may be a computing device or a sensing device, but is not limited thereto. In addition, for example, the other medication information providing device may be a medication information providing device installed in another pharmacy that synchronizes with the medication information providing device 200 in real time or non-real time using a block chain.

Short-range wireless communication unit 1500 (short-range wireless communication unit) 1510, Bluetooth communication unit 1500, BLE (Bluetooth Low Energy) communication unit 1500, short-range wireless communication unit 1500 (Near Field Communication unit), WLAN ( Wi-Fi) communication unit 1500, Zigbee communication unit 1500, infrared data association (IrDA) communication unit 1500, Wi-Fi Direct (WFD) communication unit 1500, ultra wideband (UWB) communication unit 1500 , Ant+ communication unit 1500, etc. may be included, but is not limited thereto.

The mobile communication units 1500 and 1520 transmit and receive wireless signals with at least one of a base station, an external device, and a server on a mobile communication network. Here, the wireless signal may include a voice call signal, a video call signal, or various types of data according to transmission/reception of text/multimedia messages.

The broadcast receiver 1530 receives a broadcast signal and/or broadcast-related information from outside through a broadcast channel. Broadcast channels may include satellite channels and terrestrial channels. According to an implementation example, the medication information providing apparatus 200 may not include the broadcast reception unit 1530.

In an embodiment, the communication unit 1500 may receive a video sequence including a plurality of frames from a camera installed in the medication information providing device. In an embodiment, the communication unit 1500 may transmit a command for controlling an operation of a module installed in the medication information providing device to a module installed in the medication information providing device.

The A/V (Audio/Video) input unit 1600 is for inputting an audio signal or a video signal, and may include a camera 1610 and a microphone 1620. The camera 1610 may obtain an image frame such as a still image or a video through an image sensor in a video call mode or a photographing mode. The image captured through the image sensor may be processed by the controller 1300 or a separate image processing unit (not shown). For example, an image captured by the camera 1610 may be used as information for determining whether an event has occurred.

The microphone 1620 receives an external sound signal and processes it as electrical voice data. For example, the microphone 1620 may receive an acoustic signal from an external medication information providing device or a user. The microphone 1620 may use various noise removal algorithms for removing noise generated in a process of receiving an external sound signal.

The memory 1700 may store a program for processing and control of the controller 1300, and may store data input to the medication information providing device 200 or output from the medication information providing device 200.

The memory 1700 is a flash memory 1700 type (flash memory type), a hard disk type (hard disk type), a multimedia card micro type (multimedia card micro type), a card type memory 1700 (for example, SD or XD memory (1700), RAM (Random Access Memory), SRAM (Static Random Access Memory), ROM (Read-Only Memory), EEPROM (Electrically Erasable Programmable Read-Only Memory), PROM (Programmable Read- Only Memory), a magnetic memory 1700, a magnetic disk, and an optical disk.

Programs stored in the memory 1700 can be classified into a plurality of modules according to their functions. Here, the plurality of modules are software, not hardware, meaning modules that operate functionally. For example, a UI module ( 1710), a touch screen module 1720, a notification module 1730, and the like.

The UI module 1710 may provide a specialized UI, GUI, etc. that are linked with the medication information providing device 200 for each application. The touch screen module 1720 may detect a user's touch gesture on the touch screen and transmit information on the touch gesture to the controller 1300. The touch screen module 1720 according to an embodiment may recognize and analyze a touch code. The touch screen module 1720 may be configured as separate hardware including a controller.

The notification module 1730 may generate a signal for notifying the occurrence of an event. The notification module 1730 may output a notification signal in the form of a video signal through the display unit 1210, may output a notification signal in the form of an audio signal through the sound output unit 1220, and the vibration motor 1230 It is also possible to output a notification signal in the form of a vibration signal through.

8 is an exemplary diagram of an I-Shape Extended Curvature Gabor Classifier Bunch group.

As shown in (A) of Fig. 8, one eye (I)-type extended Gabor filter group has 12 curved Gabor filters G= having 3 Gaussian widths (σ) and 4 curvatures (c). It consists of {g(σ1, c1), g(σ2, c2), g(σ3, c3), g(σ4, c4), g(σ5, c5), ..., g(σ12, c12)}.

In one Eye (I)-type extended Gabor filter group, the curvature has 4 values of c={0.0, 0.05, 0.1, 0.2}, and the Gaussian width is one of σ={0.5π, π, 2π} It has a value of σ={π}.

As such, 12 curved Gabor filters have 8 directions when the curvature is c={0.0} (ie, straight line), and when the curvature is greater than c={0.0} (ie, curved line), μ={ It has 16 directions of 0, 1, 2, ..., 15}.

In this eye (I)-type extended curved Gabor filter group, 12 curved Gabor filters are arranged along a column based on a curvature (c), and a row is arranged based on a Gaussian width (σ). After arranging along the lines, filtering is performed using four curved Gabor filters that form an "I" type.

These four "I"-shaped curved Gabor filters are four curved Gabor filters with a curvature of c = {0, 0.05, 0.1, 0.2} when the Gaussian width is σ={π}.

Accordingly, while obtaining a certain level of face recognition rate, the amount of computation can be significantly reduced and speed can be improved than when all 12 curved Gabor filters are used, and since the variance is small, a more stable face recognition performance can be secured. have.

When the features of the curved Gabor filter are grouped in this way, it is possible to reduce the dimension of the input value for the Linear Discriminant Analysis (LDA) work to be performed later, so that it is easy to expand the curved Gabor filter.

For example, although the number of features of the face image is increased by increasing the number of curve Gabor filters to be used by changing the Gaussian width and curvature, grouping features and lowering the dimension of the input value reduces the burden of learning linear discrimination (LDA). I can make it. This is also useful for improving the learning efficiency of linear discrimination analysis (LDA).

The medication information providing device 200 performs a linear discriminant analysis (LDA) operation by using an eye (I)-type extended curved Gabor filter group as an input value.

Here, the medication information providing apparatus 200 independently performs an LDA task for each eye (I)-type extended curve Gabor filter group.

To this end, the medication information providing device 200 may include a plurality of linear discrimination and analysis processing units (not shown), and LDA work for one eye (I)-type extended curved Gabor filter group for each linear discrimination and analysis processing unit Perform.

Accordingly, the medication information providing device 200 outputs a plurality of linear discrimination analysis results (ie, basis vectors) for one sub-image, and generates an observation node based on the outputted linear discrimination analysis results. And output the generated observation node.

The medication information providing apparatus 200 projects features (ie, feature vectors) of the eye (I)-type extended curved Gabor filter group for each sub-image onto a basis vector. At this time, the projected vector becomes the observation node.

The medicine-taking information providing apparatus 200 according to the present embodiment generates approximately 2400 features for one sub-image.

Here, generating about 2400 features is not only twice as time difference as outputting about 1400 features, but also has better performance and less variance than outputting 1400 features, making the face relatively stable. Because it can be recognized. This was obtained by experiment.

11 is a view for explaining the technical features of sharing medication information using a block chain network according to one disclosure.

By the start, the medication information providing device 200 may obtain user identification information, medication information, medication prescription information, medical behavior information, and the like from the user's prescription.

The medication information providing device 200 may apply a block chain to block forgery and alteration of the user's medication information and the user's biometric/body information. For example, the medication information providing device uses the user's information (e.g., parameter values used for prediction, effects and side effects on medication, etc.) set by the user as an encryption key and blocks Can be stored on the chain.

In this case, the arbitrary value may be 12 or more digits, and is a value managed by a central server, and the biosignal value may be obtained using a management app, that is, a function of a wallet included in the medication information providing device. For example, the biosignal value may include fingerprint recognition, face recognition, iris recognition, and the like.

In addition, when patient information is propagated in a block form to a pharmaceutical company's node, encryption is automatically applied and it is difficult for the pharmaceutical company to refer to it immediately. At this time, the pharmaceutical company may obtain the patient's individual key by paying a predetermined fee to the central server to refer to the patient's information.

12 is a diagram for describing an embodiment related to non-contact sensing according to an initiation.

For example, a method of sensing the user's state when the user is driving will be described. The device for sensing the user's state may be separately mounted on the user's moving means or included in the moving means. It is not limited thereto.

The sensing device may sense a state of a driving user in real time. For example, information related to the user's biometric information, such as the user's heart rate, the number of breaths, the ratio of components of air in the breath, the user's voice state, and the user's posture, may be sensed.

In this case, the sensing device may transmit sensing information on the state of the user to the medication information providing device. In addition, the sensing device may diagnose the user's condition by using the sensing information on the user's condition.For example, the sensing device measures a value for the user's heart rate or breathing activity, which is outside the range of the average value. In this case, it can be determined that the user's fatigue has increased. In this case, the sensing device may transmit information indicating that the user's fatigue has increased to the medication information providing device.

The sensing device may include a high-speed radar chip, at least one biosensor, or environmental sensors. The function of each sensor can be intuitively inferred by a person skilled in the art from its name, and the type and function of the sensor are not limited.

In addition, as described above, when a pharmaceutical company wants to view patient information using a patient's individual key, it can transmit an information reference request to the patient, and at this time, the patient receiving the information reference request allows the information reference You can send an answer. In this process, the patient can be paid a predetermined fee. At this time, the fee can be received through the blockchain. Some embodiments may also be implemented in the form of a recording medium including instructions executable by a computer, such as a program module executed by a computer. Computer-readable media can be any available media that can be accessed by a computer, and includes both volatile and nonvolatile media, removable and non-removable media. Further, the computer-readable medium may include a computer storage medium. Computer storage media includes both volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data.

In addition, in the present specification, the “unit” may be a hardware component such as a processor or a circuit, and/or a software component executed by a hardware configuration such as a processor.

The above description of the present invention is for illustrative purposes only, and those of ordinary skill in the art to which the present invention pertains will be able to understand that other specific forms can be easily modified without changing the technical spirit or essential features of the present invention will be. Therefore, it should be understood that the embodiments described above are illustrative and non-limiting in all respects. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as being distributed may also be implemented in a combined form.

The scope of the present invention is indicated by the claims to be described later rather than the detailed description, and all changes or modified forms derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention. do.

Claims (12)

Acquiring the user's medication history information from the server using the user's identification information;
Acquiring drug information prescribed by the user from a drug prescription related document provided by the user;
Obtaining current state information such as the user's body temperature, heart rate, the user's blood pressure, and blood sugar information from the user terminal;
Acquiring surrounding environment information including temperature, humidity, fine dust concentration, and weather information around a location where the user is currently located from the user terminal or server;
Obtaining health status information including at least one of a user's psychological status, drinking status, pain status, meal information, allergy information, family history information, and sleep status information from the user terminal;
Based on the result of learning medical identification information, disease name information, diagnosis name information, medical history information, medical treatment history information, information on prescribed drugs, and drug medication information corresponding to the medical identification information Obtaining an artificial intelligence first learning model based on;
Using the artificial intelligence first learning model, based on at least one of the user's medication history information, the medication information, and the user's current status information, medication information suitable for the user's current status, precautions, side effects, medications Generating first user-customized medication information including at least one of an appropriate intake number and an appropriate intake time of the drug;
Modifying the first user-customized medication information based on the surrounding environment information so that the effect of the user's intake of the medication is maximized;
Information on the current state of the user by using the first learning model. Generating time-based medication medication information according to the user's current state information by setting a weight to at least one of the user's genetic characteristic information and the surrounding environment information;
Providing at least one of the first user-customized medication information, the modified first user-customized medication information, and hourly medication medication information to the user terminal;
Acquiring a second artificial intelligence learning model in which medication information suitable for each situation is learned by using the health status information;
Generating question information related to the first customized medication information by using the artificial intelligence second learning model, and providing the generated question information to the user terminal;
Receiving response information for the question information from the user terminal; And
Providing second user-customized medication information according to the state of the user who is taking the medication by modifying the first user-customized medication information based on the answer information; including, patient-customized medication information providing method.
delete delete delete The method of claim 1,
Providing the user-customized medication information to the user terminal,
Providing notification information according to a time when the user should take the medicine;
Transmitting question information to a user terminal after a certain period of time for the user to take the medicine has elapsed; And
Including, providing customized patient medication information, providing a warning notification to the user terminal when the response information to the question information is not received from the user terminal. The method of claim 1,
Based on the answer information, detecting new effect information or new side effect information that is not included in the medication medication information; And
Generating additional medication information by matching the current state information of the user with new effect information or new side effect information;
Transmitting the additional medication information to a pharmaceutical company server that manufactures the pharmaceutical; containing, patient-customized medication information providing method. The method of claim 6,
When receiving a continuous request for the additional medication information from the pharmaceutical company server, requesting additional question information related to the additional medication information to the pharmaceutical company server;
Transmitting the additional question information to a user terminal upon receiving additional question information from the pharmaceutical company server;
In response to receiving additional response information from the user terminal, generating new additional medication information based on the additional response information; Containing, patient-customized medication information providing method. The method of claim 7,
Receiving a cryptocurrency-based remuneration from the pharmaceutical company server by providing the additional medication information to the pharmaceutical company server; And
In response to receiving the additional response information from the user terminal, providing a remuneration based on cryptocurrency to the account of the user terminal; Containing, patient customized medication information providing method. The method of claim 1,
Encrypting the first user-customized medication information and the second user-customized medication information using a blockchain; And
Storing the encrypted first user-customized medication information and the second user-customized medication information to be provided to at least one terminal authenticated through the block chain; Containing, patient-customized medication information providing method. The method of claim 9,
For automatic authentication of the at least one terminal, first authentication information is generated based on user identification information, and the first authentication information is included in the IN area of the transaction, and drug prescription information, user identification information, and individual A block containing information consent in the OUT area of the transaction is stored in the blockchain,
A block that generates second authentication information based on a first random number, includes the second authentication information in the IN area of the transaction, and includes drug prescription information and user identification information in the OUT area of the transaction Is stored in the blockchain, and the second authentication information is issued as an authentication code,
A block that generates third authentication information based on a second random number, includes the third authentication information in the IN area of the transaction, and includes drug prescription information and user identification information in the OUT area of the transaction Is stored in the blockchain, and the third authentication information is issued as an access token,
Search the blockchain based on the user identification information included in the patient-customized medication information request requested from the at least one terminal to confirm the consent and access token of personal information corresponding to the first authentication information and the third authentication information, If the personal information consent and access token exist, providing the patient-tailored medication information to the at least one terminal, patient-tailored medication information providing method. The method of claim 1,
The step of acquiring drug information prescribed by the user,
OCR (optical character reader) reads an image of at least one of the user's medical certificate, medical card, prescription, and insurance certificate, and from the read OCR information, the user's insurance contract information, personal characteristic information, prescribed drug information, and medication A method of providing patient-tailored medication information, characterized in that acquiring at least one of information and treatment information. A computer program stored in a computer-readable medium, wherein the computer program includes instructions for performing at least one of the steps of claim 1.

Images